XACT Robotics Earns FDA Clearance for Remote Control Unit
October 11, 2022
XACT Robotics, which develops a comprehensive robotic system for interventional procedures, has announced that its ACE Xtend Remote Control Unit has received clearance from the Food and Drug Administration (FDA). This allows users to robotically insert and steer the XACT ACE Robotic System remotely from the control room. This feature for CT-guided percutaneous procedures is designed to improve physician workflows while limiting physician and other users’ exposure to radiation and reducing physical strain.
The XACT ACE Robotic System (right) integrates image-guided planning and monitoring with patented S-Drive technology to deliver various instruments to a desired target in the body with accuracy, consistency and efficiency. The goal for the company is to advance the field of radiology with cutting-edge technology that supports earlier patient diagnosis and treatment.
“The XACT ACE Robotic System has already allowed users to make percutaneous procedures, such as ablations, drainages and biopsies, more accurate, consistent and efficient,” said Shai Meltzer, CEO of XACT Robotics. “The addition of ACE Xtend has the potential to further increase efficiencies for the care team with a streamlined workflow that helps reduce the time in which physicians and other users are exposed to harmful radiation during standard procedures.”
“Interventional radiology is among the medical specialties that are facing a physician shortage in the coming years and technologies that can improve their efficiencies are crucial,” said Dr. Jeffrey Solomon, vice president of medical affairs at XACT. “By equipping different users with tools that can standardize the procedure and potentially shorten procedure times, we can maximize the number of patients they see and help to mitigate the gap between the patient population and the physician population.”
XACT said its robotic system has been proven to achieve unparalleled 1.7mm tip-to-target average accuracy upon first insertion based on data obtained from company clinical studies for biopsy procedures. By providing accurate and actionable results for medical diagnosis, the system aims to enhance early detection and improve patient outcomes.
For more details on the company and technology, visit the XACT Robotics website here.
